Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study
dc.contributor.author | Nepogodiev, D | |
dc.contributor.author | Bhangu, A | |
dc.contributor.author | Glasbey, JC | |
dc.contributor.author | Li, E | |
dc.contributor.author | Omar, OM | |
dc.contributor.author | Simoes, JF | |
dc.contributor.author | Abbott, TE | |
dc.contributor.author | Alser, O | |
dc.contributor.author | Arnaud, AP | |
dc.contributor.author | Bankhead-Kendall, BK | |
dc.contributor.author | Breen, K | |
dc.contributor.author | Cuhna, MF | |
dc.contributor.author | Davidson, GH | |
dc.contributor.author | Saverio, SD | |
dc.contributor.author | Gallo, G | |
dc.contributor.author | Griffiths, EA | |
dc.contributor.author | Gujjuri, RR | |
dc.contributor.author | Hutchinson, PJ | |
dc.contributor.author | Kaafarani, HM | |
dc.contributor.author | Lederhuber, H | |
dc.contributor.author | Löffler, MW | |
dc.contributor.author | Mashbari, HN | |
dc.contributor.author | Minaya-Bravo, A | |
dc.contributor.author | Morton, DG | |
dc.contributor.author | Moszkowicz, D | |
dc.contributor.author | Pata, F | |
dc.contributor.author | Tsoulfas, G | |
dc.contributor.author | Venn, ML | |
dc.contributor.author | Cox, D | |
dc.contributor.author | Roslani, AC | |
dc.contributor.author | Alakoloko, FM | |
dc.contributor.author | Vries, JP | |
dc.contributor.author | Aaraj, MA | |
dc.contributor.author | Abbott, SJ | |
dc.contributor.author | Abdalla, MO | |
dc.contributor.author | Abdelaal, AS | |
dc.contributor.author | Ademuyiwa, AO | |
dc.contributor.author | Aherne, TM | |
dc.date.accessioned | 2022-09-01T08:46:32Z | |
dc.date.available | 2022-09-01T08:46:32Z | |
dc.date.issued | 2020 | |
dc.description | Scholarly article | en_US |
dc.description.abstract | Background: The impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on postoperative recovery needs to be understood to inform clinical decision making during and after the COVID-19 pandemic. This study reports 30-day mortality and pulmonary complication rates in patients with perioperative SARS-CoV-2 infection. Methods: This international, multicentre, cohort study at 235 hospitals in 24 countries included all patients undergoing surgery who had SARS-CoV-2 infection confirmed within 7 days before or 30 days after surgery. The primary outcome measure was 30-day postoperative mortality and was assessed in all enrolled patients. The main secondary outcome measure was pulmonary complications, defined as pneumonia, acute respiratory distress syndrome, or unexpected postoperative ventilation. Findings: This analysis includes 1128 patients who had surgery between Jan 1 and March 31, 2020, of whom 835 (74·0%) had emergency surgery and 280 (24·8%) had elective surgery. SARS-CoV-2 infection was confirmed preoperatively in 294 (26·1%) patients. 30-day mortality was 23·8% (268 of 1128). Pulmonary complications occurred in 577 (51·2%) of 1128 patients; 30-day mortality in these patients was 38·0% (219 of 577), accounting for 81·7% (219 of 268) of all deaths. In adjusted analyses, 30-day mortality was associated with male sex (odds ratio 1·75 [95% CI 1·28-2·40], p<0·0001), age 70 years or older versus younger than 70 years (2·30 [1·65-3·22], p<0·0001), American Society of Anesthesiologists grades 3-5 versus grades 1-2 (2·35 [1·57-3·53], p<0·0001), malignant versus benign or obstetric diagnosis (1·55 [1·01-2·39], p=0·046), emergency versus elective surgery (1·67 [1·06-2·63], p=0·026), and major versus minor surgery (1·52 [1·01-2·31], p=0·047). Interpretation: Postoperative pulmonary complications occur in half of patients with perioperative SARS-CoV-2 infection and are associated with high mortality. Thresholds for surgery during the COVID-19 pandemic should be higher than during normal practice, particularly in men aged 70 years and older. Consideration should be given for postponing non-urgent procedures and promoting non-operative treatment to delay or avoid the need for surgery. | en_US |
dc.identifier.citation | COVIDSurg Collaborative. Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study. Lancet. 2020 Jul 4;396(10243):27-38. doi: 10.1016/S0140-6736(20)31182-X. Epub 2020 May 29. Erratum in: Lancet. 2020 Jun 9;: PMID: 32479829; PMCID: PMC7259900. | en_US |
dc.identifier.uri | https://ir.unilag.edu.ng/handle/123456789/11208 | |
dc.language.iso | en | en_US |
dc.publisher | Elsevier Ltd | en_US |
dc.subject | respiratory syndrome coronavirus 2 (SARS-CoV-2) | en_US |
dc.subject | Mortality | en_US |
dc.subject | pulmonary complication rates | en_US |
dc.subject | Patients | en_US |
dc.subject | pneumonia | en_US |
dc.subject | Research Subject Categories::MEDICINE::Surgery | en_US |
dc.title | Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study | en_US |
dc.type | Article | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Mortality and pulmonary complications in patients.pdf
- Size:
- 876.28 KB
- Format:
- Adobe Portable Document Format
- Description:
- Main article
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: